Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where David A. Kau is active.

Publication


Featured researches published by David A. Kau.


Molecular Microbiology | 2006

A glutamic acid 3‐methyltransferase encoded by an accessory gene locus important for daptomycin biosynthesis in Streptomyces roseosporus

Kien T. Nguyen; David A. Kau; Jian-Qiao Gu; Paul Brian; Stephen K. Wrigley; Richard H. Baltz; Vivian Miao

In many peptide antibiotics, modified amino acids are important for biological activity. The amino acid 3‐methyl‐glutamic acid (3mGlu) has been found only in three cyclic lipopeptide antibiotics: daptomycin and the A21978C family produced by Streptomyces roseosporus, calcium‐dependent antibiotic produced by Streptomyces coelicolor and A54145 produced by Streptomyces fradiae. We studied the non‐ribosomal peptide synthetase genes involved in A21978C biosynthesis and the downstream genes, dptG, dptH, dptI and dptJ predicted to encode a conserved protein of unknown function, a thioesterase, a methyltransferase (MTase) and a tryptophan 2,3‐dioxygenase respectively. Deletion of dptGHIJ reduced overall lipopeptide yield and led to production of a series of novel A21978C analogues containing Glu12 instead of 3mGlu12. Complementation by only dptI, or its S. coelicolor homologue, glmT, restored the biosynthesis of the 3mGlu‐containing compounds in the mutant. Compared with A21978C, the Glu12‐containing derivatives were less active against Staphylococcus aureus. Further genetic analyses showed that members of the dptGHIJ locus cooperatively contributed to optimal A21978C production; deletion of dptH, dptI or dptJ genes reduced the yield significantly, while expression of dptIJ or dptGHIJ from the strong ermEp* promoter substantially increased lipopeptide production. The results indicate that these genes play important roles in the biosynthesis of daptomycin, and that dptI encodes a Glu MTase.


Chemistry & Biology | 2006

Genetic Engineering in Streptomyces roseosporus to Produce Hybrid Lipopeptide Antibiotics

Vivian Miao; Marie-François Coëffet-Le Gal; Kien T. Nguyen; Paul Brian; Julia Penn; Andrew Whiting; Jonathan Steele; David A. Kau; Steve Martin; Robert Ford; Trevor Gibson; Mario Bouchard; Stephen K. Wrigley; Richard H. Baltz


The Journal of Antibiotics | 2000

Novel Streptopyrroles from Streptomyces rimosus with Bacterial Protein Histidine Kinase Inhibitory and Antimicrobial Activities

Sally J. Trew; Stephen K. Wrigley; Lydie Pairet; Jess Sohal; Patrick Shanu-Wilson; Martin A. Hayes; Steven M. Martin; Ravi N. Manohar; M. Inês Chicarelli-Robinson; David A. Kau; Colin V Byrne; Elizabeth M. H. Wellington; Janet M. Moloney; Judith A. K. Howard; Donald Hupe; Eric R. Olson


The Journal of Antibiotics | 2002

Identifying Protein Kinase Inhibitors Using an Assay Based on Inhibition of Aerial Hyphae Formation in Streptomyces

Barbara Waters; Geeta Saxena; Yangsheng Wanggui; David A. Kau; Stephen K. Wrigley; Richard W. Stokes; Julian Davies


The Journal of Antibiotics | 1999

A novel (6S)-4,6-dimethyldodeca-2E,4E-dienoyl ester of phomalactone and related alpha-pyrone esters from a Phomopsis sp. with cytokine production inhibitory activity.

Stephen K. Wrigley; Roya Sadeghi; Sangeeta Bahl; Andrew Whiting; A. Martyn Ainsworth; Steven M. Martin; Werner Katzer; Robert Ford; David A. Kau; Neil Robinson; Martin A. Hayes; Claire Elcock; Thomas Mander; Michael Moores


The Journal of Antibiotics | 2001

Novel Reduced Benzo[j]fluoranthen-3-ones from Cladosporium cf. cladosporioides with Cytokine Production and Tyrosine Kinase Inhibitory Properties

Stephen K. Wrigley; A. Martyn Ainsworth; David A. Kau; Steven M. Martin; Sangeeta Bahl; Jenny Seugkin Tang; David James Hardick; Philip Rawlins; Roya Sadheghi; Michael Moore


Archive | 1997

Cytokine production inhibitors

Stephen K. Wrigley; Sangeeta Bahl; Roya Mansour Sadeghi Guilani; Michael Moore; Werner Katzer; Steven M. Martin; David A. Kau; Andrew Whiting; Neil Robinson; Martin Alistair Hayes; Thomas Mander


Archive | 1999

Cytokine production and tyrosine kinase inhibitors

Roya Mansour Sadeghi Guilani; Stephen K. Wrigley; Sangeeta Bahl; Steven M. Martin; David A. Kau; Jenny Seugkin Tang; Michael Moore; David James Hardick


Archive | 2006

Scale-Up of Natural Product Isolation

Steven M. Martin; David A. Kau; Stephen K. Wrigley


Archive | 2000

Signal transduction inhibitors from microorganisms

Stephen K. Wrigley; Martin A. Hayes; Robert Thomas; Ewan J. T. Chrystal; Neville Nicholson; David A. Kau; Barbara Waters; Julian Davies

Collaboration


Dive into the David A. Kau's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge